Literature DB >> 12966790

[Chronic diarrhea in a 43-year-old patient].

J Strehl1, M Schepke, E Wardelmann, W H Caselmann, T Sauerbruch.   

Abstract

A 43-year old patient came to our clinic with chronic diarrhea. Determination of the faecal alpha 1-antitrypsin-clearance led to the diagnosis of exsudative enteropathy. Blood counts showed pronounced lymphocytopenia. Histopathological findings from intestinal and colorectal biopsies showed diffuse lymphangiectasis. Following exclusion of secondary types, our diagnosis was primary intestinal lymphangiectasis. Additional distinctive morphological and anamnestic features strongly suggested presence of Noonan's syndrome. Characteristic manifestations of Noonan's syndrome include changes in the lymphatic vessels in accordance with primary lymphangiectasis. Frequently, these changes are localized in the lungs. To date, only rare cases of intestinal lymphangiectasia in Noonan's syndrome have been reported. Treatment consisted of a protein-rich diet, with reduced fat content enriched by middle-chain fatty acids, as well as twice-daily injections of 200 micrograms octreotide. With this therapy, the symptoms improved.

Entities:  

Mesh:

Year:  2003        PMID: 12966790     DOI: 10.1007/s00108-003-0856-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract.

Authors:  I J Fuss; W Strober; B A Cuccherini; G R Pearlstein; X Bossuyt; M Brown; T A Fleisher; K Horgan
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

Review 2.  Protein-losing enteropathy.

Authors:  T A Waldmann
Journal:  Gastroenterology       Date:  1966-03       Impact factor: 22.682

3.  Short stature in Noonan syndrome: response to growth hormone therapy.

Authors:  J M Kirk; P R Betts; G E Butler; M D Donaldson; D B Dunger; D I Johnston; C J Kelnar; D A Price; P Wilton
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

4.  Octreotide for protein-losing enteropathy with intestinal lymphangiectasia.

Authors:  D J Bac; P M Van Hagen; P T Postema; A M ten Bokum; P E Zondervan; M van Blankenstein
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

5.  Computed tomography after lymphangiography in the diagnosis of intestinal lymphangiectasia with protein-losing enteropathy in Noonan's syndrome.

Authors:  M Keberle; H Mörk; M Jenett; D Hahn; M Scheurlen
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

6.  Feeding difficulties and foregut dysmotility in Noonan's syndrome.

Authors:  N Shah; M Rodriguez; D S Louis; K Lindley; P J Milla
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

7.  Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up.

Authors:  C E MacFarlane; D C Brown; L B Johnston; M A Patton; D B Dunger; M O Savage; W J McKenna; C J Kelnar
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

9.  Pulmonary lymphangiectasis in Noonan syndrome.

Authors:  R J Hernandez; A M Stern; A Rosenthal
Journal:  AJR Am J Roentgenol       Date:  1980-01       Impact factor: 3.959

10.  Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.

Authors:  J J Bernier; C Florent; C Desmazures; C Aymes; C L'Hirondel
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

View more
  3 in total

Review 1.  Primary intestinal lymphangiectasia: four case reports and a review of the literature.

Authors:  Jie Wen; Qingya Tang; Jiang Wu; Ying Wang; Wei Cai
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

Review 2.  Lymphatic Phenotype of Noonan Syndrome: Innovative Diagnosis and Possible Implications for Therapy.

Authors:  Lotte E R Kleimeier; Caroline van Schaik; Erika Leenders; Maxim Itkin; Willemijn M Klein; Jos M T Draaisma
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.

Authors:  Rudolf Huber; Georg Semmler; Alexander Mayr; Felix Offner; Christian Datz
Journal:  World J Gastroenterol       Date:  2020-12-08       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.